upfront use of osimertinib in egfr nsclc
Published 7 years ago • 2K plays • Length 7:45Download video MP4
Download video MP3
Similar videos
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
5:47
egfr tkis for upfront treatment of nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
8:55
global perspectives on use of osimertinib in egfr nsclc
-
3:17
osimertinib in egfr-positive nsclc with brain metastases
-
4:41
upfront egfr-targeted therapy for nsclc
-
6:51
osimertinib as frontline therapy in egfr-positive nsclc
-
2:02
case 4: upfront osimertinib in metastatic egfr nsclc
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc